Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Titel:
Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Auteur:
Knuf, Markus Leroux-Roels, Geert Rümke, Hans. C. Abarca, Katia Rivera, Luis Lattanzi, Maria Pedotti, Paola Arora, Ashwani Kieninger-Baum, Dorothee Della Cioppa, Giovanni